In Italy, the life sciences sector is experiencing major growth thanks to the excellence of the country’s scientific research and the existence of a framework of enterprises which, despite the limitations inherent in being small-sized companies, have a good capacity for innovation.
This is the title we have given the third Life Sciences Technology Forum – which has become an essential, regular event on the national agenda – to underscore the sense of urgency and need to provide clear and concrete answers so that this sector will increasingly have the tools for communicating its standing in Italy and the world. There is no time to waste. For us, “today” is already late!
This report summarizes and collates the main points, observations and findings of the third period of study of the Life Sciences Technology Forum Advisory Board, created in 2015 in collaboration with Assobiotec (Italian Association for the Development of Biotechnologies), Alisei (Advanced Life Science in Italy – National Life Sciences Cluster) and a number of biotech companies working in Italy, with the goal of contributing to the promotion of the development of the innovation ecosystem within the life sciences sector in Italy.
In 2017, the mission of this initiative is “making Italy the place we would like for the biopharmaceuticals of tomorrow: a leading player in the research, development, production and access to innovative, biotech products.” This process—which benefited from the contribution of a top-level Scientific Committee—concentrated on three key areas: